Financial Ratios Sociedad Química y Minera de Chile S.A.
Stocks
SQM
US8336351056
Specialty Chemicals
|
Market Closed -
Other stock markets
|
After hours 05:29:17 am | |||
| 75.66 USD | +3.99% |
|
76.62 | +1.27% |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 9.81 | 38.75 | 16.07 | 5.8 | 5.23 | |||||
Return on Total Capital | 11.55 | 50.47 | 20.08 | 6.68 | 5.95 | |||||
Return On Equity % | 22.02 | 96.08 | 38.48 | -7.39 | 9.67 | |||||
Return on Common Equity | 22.07 | 96.71 | 38.6 | -7.56 | 10.84 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 38.08 | 53.56 | 41.18 | 29.22 | 29.56 | |||||
SG&A Margin | 4.15 | 1.33 | 2.35 | 4.11 | 4.27 | |||||
EBITDA Margin % | 39.63 | 54.28 | 42.3 | 30.81 | 32.28 | |||||
EBITA Margin % | 32.8 | 52.24 | 38.92 | 23.92 | 23.95 | |||||
EBIT Margin % | 32.51 | 52.09 | 38.77 | 23.78 | 23.79 | |||||
Income From Continuing Operations Margin % | 20.69 | 36.55 | 27.05 | -8.78 | 14 | |||||
Net Income Margin % | 20.45 | 36.47 | 26.95 | -8.93 | 12.85 | |||||
Net Avail. For Common Margin % | 20.45 | 36.47 | 26.95 | -8.93 | 12.85 | |||||
Normalized Net Income Margin | 18.23 | 32.17 | 23.8 | 13.44 | 12.3 | |||||
Levered Free Cash Flow Margin | 13.19 | 29.32 | -8.6 | 6.13 | 9.39 | |||||
Unlevered Free Cash Flow Margin | 14.89 | 29.82 | -7.61 | 8.61 | 11.68 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.48 | 1.19 | 0.66 | 0.39 | 0.35 | |||||
Fixed Assets Turnover | 1.49 | 4.41 | 2.31 | 1.1 | 0.97 | |||||
Receivables Turnover (Average Receivables) | 5.47 | 12.21 | 7.82 | 6.53 | 7.7 | |||||
Inventory Turnover (Average Inventory) | 1.56 | 3.35 | 2.47 | 1.84 | 1.84 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 4.62 | 2.29 | 2.5 | 2.51 | 3.27 | |||||
Quick Ratio | 3.3 | 1.59 | 1.38 | 1.58 | 2.13 | |||||
Operating Cash Flow to Current Liabilities | 0.83 | 1.34 | -0.08 | 0.57 | 0.74 | |||||
Days Sales Outstanding (Average Receivables) | 66.74 | 29.89 | 46.68 | 56.04 | 47.42 | |||||
Days Outstanding Inventory (Average Inventory) | 234.46 | 108.9 | 147.87 | 198.5 | 198.47 | |||||
Average Days Payable Outstanding | 47.32 | 21.36 | 33.43 | 52.72 | 48.5 | |||||
Cash Conversion Cycle (Average Days) | 253.88 | 117.43 | 161.12 | 201.82 | 197.39 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 83.75 | 60.4 | 81.64 | 93.26 | 59.16 | |||||
Total Debt / Total Capital | 45.58 | 37.66 | 44.95 | 48.26 | 37.17 | |||||
LT Debt/Equity | 81.91 | 49.55 | 58.75 | 70.44 | 53.03 | |||||
Long-Term Debt / Total Capital | 44.58 | 30.89 | 32.34 | 36.45 | 33.32 | |||||
Total Liabilities / Total Assets | 54.35 | 54.41 | 52.44 | 54.78 | 44.48 | |||||
EBIT / Interest Expense | 11.34 | 61.95 | 23.09 | 5.72 | 6.06 | |||||
EBITDA / Interest Expense | 13.93 | 64.65 | 25.33 | 7.53 | 8.38 | |||||
(EBITDA - Capex) / Interest Expense | 8.27 | 54.6 | 16.53 | 2.37 | 3.49 | |||||
Total Debt / EBITDA | 2.36 | 0.51 | 1.43 | 3.42 | 3.17 | |||||
Net Debt / EBITDA | 0.24 | -0.11 | 0.69 | 1.69 | 1.36 | |||||
Total Debt / (EBITDA - Capex) | 3.97 | 0.61 | 2.19 | 10.86 | 7.6 | |||||
Net Debt / (EBITDA - Capex) | 0.4 | -0.13 | 1.06 | 5.36 | 3.26 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 57.51 | 274.19 | -30.28 | -39.35 | 1.05 | |||||
Gross Profit, 1 Yr. Growth % | 125.76 | 426.24 | -46.4 | -56.96 | 2.2 | |||||
EBITDA, 1 Yr. Growth % | 127 | 411.75 | -45.66 | -55.83 | 5.86 | |||||
EBITA, 1 Yr. Growth % | 196.32 | 495 | -48.06 | -62.72 | 1.16 | |||||
EBIT, 1 Yr. Growth % | 204.65 | 498.53 | -48.12 | -62.8 | 1.07 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 251.75 | 560.97 | -48.4 | -119.69 | -261.11 | |||||
Net Income, 1 Yr. Growth % | 255.86 | 567.23 | -48.48 | -120.09 | -245.45 | |||||
Normalized Net Income, 1 Yr. Growth % | 259.29 | 558.93 | -48.41 | -65.76 | -7.52 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 227.88 | 567.24 | -48.48 | -120.09 | -245.45 | |||||
Accounts Receivable, 1 Yr. Growth % | 79.18 | 61.14 | -23.57 | -32.38 | 10.01 | |||||
Inventory, 1 Yr. Growth % | 8.3 | 50.73 | -0.54 | -4.08 | 5.95 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 16.83 | 35.01 | 32.12 | 22.66 | 8.68 | |||||
Total Assets, 1 Yr. Growth % | 46.19 | 50.68 | 8.19 | -1.79 | 26.18 | |||||
Tangible Book Value, 1 Yr. Growth % | 55.95 | 59.38 | 13.63 | -7.11 | -37.15 | |||||
Common Equity, 1 Yr. Growth % | 49.85 | 53.91 | 12.95 | -6.69 | 10.28 | |||||
Cash From Operations, 1 Yr. Growth % | 351.35 | 395.74 | -104.37 | -814.93 | 3.11 | |||||
Capital Expenditures, 1 Yr. Growth % | 44.21 | 94.79 | 21.91 | -11.94 | -9.79 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -348.16 | 729.72 | -120.46 | -143.68 | 54.8 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -516.32 | 647.74 | -117.79 | -169.47 | 37.2 | |||||
Dividend Per Share, 1 Yr. Growth % | 246.29 | 1.58T | -80.68 | - | - | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 21.35 | 142.78 | 61.52 | -34.97 | -21.72 | |||||
Gross Profit, 2 Yr. CAGR % | 39.51 | 244.68 | 67.95 | -51.97 | -33.68 | |||||
EBITDA, 2 Yr. CAGR % | 33.86 | 241.08 | 66.76 | -51.01 | -31.62 | |||||
EBITA, 2 Yr. CAGR % | 45.59 | 320.26 | 75.8 | -56 | -38.59 | |||||
EBIT, 2 Yr. CAGR % | 45.01 | 327.39 | 76.22 | -56.06 | -38.68 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 45.27 | 382.18 | 84.68 | -68.13 | -43.68 | |||||
Net Income, 2 Yr. CAGR % | 45.09 | 387.28 | 85.41 | -67.83 | -45.94 | |||||
Normalized Net Income, 2 Yr. CAGR % | 45.29 | 387.04 | 84.37 | -57.97 | -43.73 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 39.27 | 367.74 | 85.41 | -67.83 | -45.94 | |||||
Accounts Receivable, 2 Yr. CAGR % | 25.2 | 69.92 | 10.98 | -28.11 | -13.23 | |||||
Inventory, 2 Yr. CAGR % | 9.72 | 27.77 | 22.44 | -2.33 | 0.81 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 13.35 | 25.59 | 33.56 | 27.3 | 15.46 | |||||
Total Assets, 2 Yr. CAGR % | 22.63 | 49.84 | 27.68 | 3.08 | 11.32 | |||||
Tangible Book Value, 2 Yr. CAGR % | 26.2 | 57.66 | 34.57 | 2.74 | -23.59 | |||||
Common Equity, 2 Yr. CAGR % | 23.49 | 51.87 | 31.85 | 2.66 | 1.44 | |||||
Cash From Operations, 2 Yr. CAGR % | 38.8 | 373.03 | -53.44 | -44.11 | 171.51 | |||||
Capital Expenditures, 2 Yr. CAGR % | 20.26 | 67.61 | 54.1 | 3.61 | -10.87 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 261.02 | 354.38 | 30.29 | -70.27 | -17.78 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 144.09 | 458.61 | 15.32 | -65.07 | -2.37 | |||||
Dividend Per Share, 2 Yr. CAGR % | -21.61 | 663.87 | 80.43 | - | - | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 8.1 | 76.63 | 60.17 | 16.53 | -24.68 | |||||
Gross Profit, 3 Yr. CAGR % | 11.8 | 117.17 | 85.36 | 6.68 | -38.22 | |||||
EBITDA, 3 Yr. CAGR % | 8.46 | 109.41 | 84.9 | 7.09 | -36.66 | |||||
EBITA, 3 Yr. CAGR % | 11.74 | 132.9 | 109.34 | 4.83 | -41.92 | |||||
EBIT, 3 Yr. CAGR % | 11.43 | 132.75 | 111.62 | 4.93 | -42 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 10.24 | 140.72 | 128.92 | -12.43 | -45.3 | |||||
Net Income, 3 Yr. CAGR % | 10 | 141.28 | 130.42 | -11.61 | -46.8 | |||||
Normalized Net Income, 3 Yr. CAGR % | 10.22 | 140.66 | 130.44 | 5.19 | -45.34 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 7.04 | 134.78 | 124.22 | -11.61 | -46.8 | |||||
Accounts Receivable, 3 Yr. CAGR % | 12.38 | 36.19 | 30.19 | -5.92 | -16.82 | |||||
Inventory, 3 Yr. CAGR % | 9.02 | 21.97 | 17.53 | 12.87 | 0.36 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 12.38 | 20.15 | 27.73 | 29.82 | 20.76 | |||||
Total Assets, 3 Yr. CAGR % | 18.18 | 32.19 | 34.43 | 16.99 | 10.27 | |||||
Tangible Book Value, 3 Yr. CAGR % | 16.82 | 36.41 | 41.35 | 18.93 | -12.79 | |||||
Common Equity, 3 Yr. CAGR % | 15.12 | 32.9 | 37.6 | 17.5 | 5.14 | |||||
Cash From Operations, 3 Yr. CAGR % | 16.16 | 112.16 | -0.73 | 15.72 | -31.45 | |||||
Capital Expenditures, 3 Yr. CAGR % | 23.84 | 41.23 | 50.73 | 27.88 | -1.06 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 18.93 | 376.86 | 61.65 | -9.82 | -48.47 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 18.28 | 254.79 | 77.05 | -3.01 | -44.88 | |||||
Dividend Per Share, 3 Yr. CAGR % | -27.03 | 117.95 | 124.23 | - | - | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 8.1 | 37.78 | 26.94 | 18.43 | 20.29 | |||||
Gross Profit, 5 Yr. CAGR % | 12.3 | 49.72 | 31.56 | 18.77 | 22.88 | |||||
EBITDA, 5 Yr. CAGR % | 8.54 | 45.57 | 28.86 | 17.12 | 24.2 | |||||
EBITA, 5 Yr. CAGR % | 14.73 | 53.49 | 33.99 | 19.59 | 28.17 | |||||
EBIT, 5 Yr. CAGR % | 14.55 | 53.41 | 33.9 | 19.47 | 28.94 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 16 | 55.65 | 35.51 | 7.22 | 30.64 | |||||
Net Income, 5 Yr. CAGR % | 16.04 | 55.64 | 35.55 | 7.77 | 29.02 | |||||
Normalized Net Income, 5 Yr. CAGR % | 14.08 | 54.22 | 35.46 | 19.74 | 31.11 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 14.15 | 53.12 | 33.35 | 6.02 | 26.92 | |||||
Accounts Receivable, 5 Yr. CAGR % | 9.48 | 18.09 | 11.82 | 5.48 | 10.69 | |||||
Inventory, 5 Yr. CAGR % | 3.58 | 14.62 | 14.2 | 11.6 | 10.53 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 5.83 | 14.29 | 20.42 | 22.96 | 22.67 | |||||
Total Assets, 5 Yr. CAGR % | 10.8 | 20.29 | 22.36 | 19.67 | 24.66 | |||||
Tangible Book Value, 5 Yr. CAGR % | 7.17 | 18.36 | 23.62 | 21.79 | 10.52 | |||||
Common Equity, 5 Yr. CAGR % | 7.21 | 17.48 | 21.54 | 19.86 | 21.8 | |||||
Cash From Operations, 5 Yr. CAGR % | 5.36 | 42.09 | -19.42 | 24.45 | 48.46 | |||||
Capital Expenditures, 5 Yr. CAGR % | 28.77 | 44.81 | 35.16 | 24.77 | 22.16 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -6.66 | 36.1 | 23.42 | 57.15 | 23.08 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -5.61 | 35.35 | 17.15 | 40.37 | 39.19 | |||||
Dividend Per Share, 5 Yr. CAGR % | -9.29 | 46.43 | 4.81 | - | - |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















